ArticleCancer medicine2024

Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens.

Danilo De Novellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.